Acta Pharmaceuticals
PrivateLast Round
Seed
Oct 15, 2026
Total Funding Raised
$24M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Acta Pharmaceuticals is a biotechnology company developing therapies for the early intervention and prevention of Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acta Pharmaceuticals Comparables
Compare Acta Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galimedix Therapeutics | 82% | |
| Allyx Therapeutics, Inc. | 81% | |
| Cenna Biosciences, Inc. | 79% |
Acta Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 15, 2026 |
Acta Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Seed |
| Cure Alzheimer's Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2026
$24M round with Dolby Family Ventures and Cure Alzheimer's Fund
Recent news
Latest coverage and updates
- receives_financingOct 16, 2026
ACTA Pharmaceuticals secures $24M in Seed funding to advance its Alzheimer’s disease drug pipeline, including clinical progression of lead candidate GSM-779690T.
Acta Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Acta Pharmaceuticals's valuation, stock price, and market status.
Is Acta Pharmaceuticals a public or private company?
Acta Pharmaceuticals is a private company.
What is the current stock price of Acta Pharmaceuticals?
Acta Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Acta Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Acta Pharmaceuticals worth (valuation)?
Valuation information for Acta Pharmaceuticals is not publicly available.
Can I buy Acta Pharmaceuticals stock?
Acta Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Acta Pharmaceuticals's last funding round?
Acta Pharmaceuticals's most recent funding round was Seed on October 15, 2026.
Who are the main investors in Acta Pharmaceuticals?
Key investors in Acta Pharmaceuticals include Dolby Family Ventures, Cure Alzheimer's Fund.
Will Acta Pharmaceuticals IPO soon?
No public IPO plans have been announced for Acta Pharmaceuticals.
How can I track Acta Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Acta Pharmaceuticals's shares on secondary markets.